Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Biomarkers, Tumor"" wg kryterium: Temat


Tytuł:
Circular RNAs hsa_circ_0001438 and hsa_circ_0000417 are downregulated and upregulated, respectively, in hepatocellular carcinoma.
Autorzy:
Imanishi S; Department of Biochemistry and Genome Biology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Nagata S; Department of Biochemistry and Genome Biology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Fujita T; Department of Biochemistry and Genome Biology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Fujii H; Department of Biochemistry and Genome Biology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Pokaż więcej
Źródło:
International journal of experimental pathology [Int J Exp Pathol] 2022 Dec; Vol. 103 (6), pp. 245-251. Date of Electronic Publication: 2022 Sep 24.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomarkers, Tumor*/genetics
Biomarkers, Tumor*/metabolism
Carcinoma, Hepatocellular*/diagnosis
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/diagnosis
Liver Neoplasms*/genetics
Liver Neoplasms*/pathology
RNA, Circular*/genetics
RNA, Circular*/metabolism
Humans ; alpha-Fetoproteins/genetics ; alpha-Fetoproteins/metabolism ; Gene Expression Regulation, Neoplastic
Czasopismo naukowe
Tytuł:
Identification of Prognostic Gene Signatures by Developing a scRNA-Seq-Based Integration Approach to Predict Recurrence and Chemotherapy Benefit in Stage II-III Colorectal Cancer.
Autorzy:
Wang Z; College of Bioinformatics Science and Technology, Harbin Medical University, No. 194, Xue-Fu Road, Nangang Region, Harbin 150081, China.
Xing K; College of Bioinformatics Science and Technology, Harbin Medical University, No. 194, Xue-Fu Road, Nangang Region, Harbin 150081, China.
Zhang B; College of Bioinformatics Science and Technology, Harbin Medical University, No. 194, Xue-Fu Road, Nangang Region, Harbin 150081, China.
Zhang Y; College of Bioinformatics Science and Technology, Harbin Medical University, No. 194, Xue-Fu Road, Nangang Region, Harbin 150081, China.
Chai T; College of Bioinformatics Science and Technology, Harbin Medical University, No. 194, Xue-Fu Road, Nangang Region, Harbin 150081, China.
Geng J; College of Bioinformatics Science and Technology, Harbin Medical University, No. 194, Xue-Fu Road, Nangang Region, Harbin 150081, China.
Qin X; College of Bioinformatics Science and Technology, Harbin Medical University, No. 194, Xue-Fu Road, Nangang Region, Harbin 150081, China.
Zhang X; College of Bioinformatics Science and Technology, Harbin Medical University, No. 194, Xue-Fu Road, Nangang Region, Harbin 150081, China.
Xu C; College of Bioinformatics Science and Technology, Harbin Medical University, No. 194, Xue-Fu Road, Nangang Region, Harbin 150081, China.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Oct 18; Vol. 23 (20). Date of Electronic Publication: 2022 Oct 18.
Typ publikacji:
Journal Article
MeSH Terms:
Biomarkers, Tumor*/genetics
Biomarkers, Tumor*/metabolism
Colorectal Neoplasms*/drug therapy
Colorectal Neoplasms*/genetics
Colorectal Neoplasms*/pathology
Humans ; Prognosis ; Gene Expression Profiling ; Prospective Studies ; Single-Cell Analysis ; Chemotherapy, Adjuvant ; Neoplasm Staging
Czasopismo naukowe
Tytuł:
Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
Autorzy:
Jiang F; Department of General Surgery, PLA Strategic Support Force Characteristic Medical Center, Beijing, 100101, People's Republic of China.
Lin H; Department of General Surgery, PLA Strategic Support Force Characteristic Medical Center, Beijing, 100101, People's Republic of China.
Yan H; Department of General Surgery, PLA Strategic Support Force Characteristic Medical Center, Beijing, 100101, People's Republic of China.
Sun X; Department of General Surgery, PLA Strategic Support Force Characteristic Medical Center, Beijing, 100101, People's Republic of China.
Yang J; Department of General Surgery, PLA Strategic Support Force Characteristic Medical Center, Beijing, 100101, People's Republic of China. .
Dong M; Department of General Surgery, PLA Strategic Support Force Characteristic Medical Center, Beijing, 100101, People's Republic of China. .
Pokaż więcej
Źródło:
European journal of medical research [Eur J Med Res] 2022 Oct 17; Vol. 27 (1), pp. 205. Date of Electronic Publication: 2022 Oct 17.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*/genetics
Biomarkers, Tumor*/genetics
Biomarkers, Tumor*/metabolism
Stomach Neoplasms*/genetics
Humans ; Cytokines ; Ligands ; Prognosis ; Receptors, Cytokine ; RNA, Messenger/genetics ; Stomach/pathology
Czasopismo naukowe
Tytuł:
Single whole genome sequencing analysis blazes the trail for precision medicine.
Autorzy:
Napoli GC; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Chau CH; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Figg WD; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Pokaż więcej
Źródło:
Cancer biology & therapy [Cancer Biol Ther] 2022 Dec 31; Vol. 23 (1), pp. 134-135.
Typ publikacji:
Journal Article; Research Support, N.I.H., Intramural
MeSH Terms:
Biomarkers, Tumor*/genetics
Precision Medicine*
High-Throughput Nucleotide Sequencing ; Humans ; Mutation ; Neoplasm Recurrence, Local ; Whole Genome Sequencing
Czasopismo naukowe
Tytuł:
Protein transduction domain of translationally controlled tumor protein: characterization and application in drug delivery.
Autorzy:
Maeng J; Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, Seoul, Republic of Korea.
Lee K; Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, Seoul, Republic of Korea.
Pokaż więcej
Źródło:
Drug delivery [Drug Deliv] 2022 Dec; Vol. 29 (1), pp. 3009-3021.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Biomarkers, Tumor*/metabolism
Tumor Protein, Translationally-Controlled 1*
Administration, Intranasal ; Drug Delivery Systems ; Humans ; Insulin
Czasopismo naukowe
Tytuł:
Clinical, laboratory and genetic features of Erdheim-Chester disease patients: analysis of a retrospective cohort of two reference centers in Latin America.
Autorzy:
Guerra Soares Brandão AA; Instituto do Câncer do Estado de São Paulo (ICESP), São Paulo, Brazil.; Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo, Brazil.
Ramires Neder Abdo A; Instituto do Câncer do Estado de São Paulo (ICESP), São Paulo, Brazil.; Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo, Brazil.
Lage LAPC; Instituto do Câncer do Estado de São Paulo (ICESP), São Paulo, Brazil.; Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo Brazil.
Fatobene G; Instituto do Câncer do Estado de São Paulo (ICESP), São Paulo, Brazil.; Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo, Brazil.
Pereira J; Instituto do Câncer do Estado de São Paulo (ICESP), São Paulo, Brazil.; Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo Brazil.
Rocha V; Instituto do Câncer do Estado de São Paulo (ICESP), São Paulo, Brazil.; Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo Brazil.; Churchill Hospital, Oxford University, Oxford, UK.
Pokaż więcej
Źródło:
Hematology (Amsterdam, Netherlands) [Hematology] 2022 Dec; Vol. 27 (1), pp. 65-69.
Typ publikacji:
Letter
MeSH Terms:
Biomarkers, Tumor*
Genetic Association Studies*/methods
Genetic Predisposition to Disease*
Erdheim-Chester Disease/*diagnosis
Erdheim-Chester Disease/*genetics
Biopsy ; Bone Marrow/pathology ; Brazil ; Erdheim-Chester Disease/therapy ; Humans ; Latin America ; Mutation ; Neoplasm Staging ; Phenotype ; Retrospective Studies
Opinia redakcyjna
Tytuł:
Diagnostic value of circN4BP2L2 in type I and type II epithelial ovarian cancer.
Autorzy:
Ning L; Department of gynecologic oncology, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, 100021, Beijing, China.
Lang J; Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 100730, Beijing, China.
Long B; Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 100730, Beijing, China. .
Wu L; Department of gynecologic oncology, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, 100021, Beijing, China.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2022 Nov 24; Vol. 22 (1), pp. 1210. Date of Electronic Publication: 2022 Nov 24.
Typ publikacji:
Journal Article
MeSH Terms:
Biomarkers, Tumor*/genetics
Ovarian Neoplasms*/diagnosis
Ovarian Neoplasms*/genetics
Humans ; Female ; Carcinoma, Ovarian Epithelial/diagnosis ; Proteins/metabolism ; CA-125 Antigen
Czasopismo naukowe
Tytuł:
A handheld electronic device with the potential to detect lung cancer biomarkers from exhaled breath.
Autorzy:
Emam S; Mechanical Engineering Program, School of Science, Engineering and Technology, Pennsylvania State University, Harrisburg, Middletown, PA, 17057, USA. .
Nasrollahpour M; Department of Electrical and Computer Engineering, Northeastern University, Boston, MA, 02115, USA.
Allen JP; Department of Electrical and Computer Engineering, Northeastern University, Boston, MA, 02115, USA.
He Y; Department of Electrical and Computer Engineering, Northeastern University, Boston, MA, 02115, USA.
Hussein H; Department of Electrical and Computer Engineering, Northeastern University, Boston, MA, 02115, USA.
Shah HS; Department of Electrical and Computer Engineering, Northeastern University, Boston, MA, 02115, USA.
Tavangarian F; Mechanical Engineering Program, School of Science, Engineering and Technology, Pennsylvania State University, Harrisburg, Middletown, PA, 17057, USA.
Sun NX; Department of Electrical and Computer Engineering, Northeastern University, Boston, MA, 02115, USA.
Pokaż więcej
Źródło:
Biomedical microdevices [Biomed Microdevices] 2022 Nov 18; Vol. 24 (4), pp. 41. Date of Electronic Publication: 2022 Nov 18.
Typ publikacji:
Journal Article
MeSH Terms:
Biomarkers, Tumor*
Lung Neoplasms*/diagnosis
Humans ; Polymers/chemistry ; Lung ; Electronics
Czasopismo naukowe
Tytuł:
HE4 Tissue Expression as A Putative Prognostic Marker in Low-Risk/Low-Grade Endometrioid Endometrial Cancer: A Review.
Autorzy:
Mais V; Department of Surgical Sciences, University of Cagliari Medical School, 09042 Cagliari, Italy.
Fais ML; Department of Surgical Sciences, University of Cagliari Medical School, 09042 Cagliari, Italy.
Peiretti M; Division of Gynecology and Obstetrics (AOU di Cagliari), Department of Surgical Sciences, University of Cagliari, 09042 Cagliari, Italy.
Fanni D; Division of Pathology (AOU di Cagliari), Department of Medical Sciences and Public Health, University of Cagliari, 09042 Cagliari, Italy.
Massa E; Division of Oncology (AOU di Cagliari), Department of Medical Sciences and Public Health, University of Cagliari, 09042 Cagliari, Italy.
Carboni G; Department of Surgical Sciences, University of Cagliari Medical School, 09042 Cagliari, Italy.
Fais G; Department of Surgical Sciences, University of Cagliari Medical School, 09042 Cagliari, Italy.
Deo G; Department of Surgical Sciences, University of Cagliari Medical School, 09042 Cagliari, Italy.
Angioni S; Department of Surgical Sciences, University of Cagliari Medical School, 09042 Cagliari, Italy.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Nov 10; Vol. 29 (11), pp. 8540-8555. Date of Electronic Publication: 2022 Nov 10.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Biomarkers, Tumor*/genetics
Endometrial Neoplasms*/genetics
Endometrial Neoplasms*/pathology
Female ; Humans ; Prognosis ; Neoplasm Recurrence, Local ; RNA, Messenger
Czasopismo naukowe
Tytuł:
Automated classification of protein expression levels in immunohistochemistry images to improve the detection of cancer biomarkers.
Autorzy:
Xue ZZ; School of Biomedical Engineering and Guangdong Provincial Key Laboratory of Medical Image Processing, Southern Medical University, Guangzhou, 510515, China.; Guangdong Province Engineering Laboratory for Medical Imaging and Diagnostic Technology, Southern Medical University, Guangzhou, 510515, China.; Paul C. Lauterbur Research Center for Biomedical Imaging, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.
Li C; Paul C. Lauterbur Research Center for Biomedical Imaging, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.
Luo ZM; School of Biomedical Engineering and Guangdong Provincial Key Laboratory of Medical Image Processing, Southern Medical University, Guangzhou, 510515, China.; Guangdong Province Engineering Laboratory for Medical Imaging and Diagnostic Technology, Southern Medical University, Guangzhou, 510515, China.
Wang SS; Paul C. Lauterbur Research Center for Biomedical Imaging, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.; Peng Cheng Laboratory, Shenzhen, 518055, China.; Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangzhou, 510080, China.
Xu YY; School of Biomedical Engineering and Guangdong Provincial Key Laboratory of Medical Image Processing, Southern Medical University, Guangzhou, 510515, China. .; Guangdong Province Engineering Laboratory for Medical Imaging and Diagnostic Technology, Southern Medical University, Guangzhou, 510515, China. .
Pokaż więcej
Źródło:
BMC bioinformatics [BMC Bioinformatics] 2022 Nov 08; Vol. 23 (1), pp. 470. Date of Electronic Publication: 2022 Nov 08.
Typ publikacji:
Journal Article
MeSH Terms:
Biomarkers, Tumor*
Neoplasms*/diagnosis
Immunohistochemistry ; Neural Networks, Computer ; Machine Learning ; Proteins
Czasopismo naukowe
Tytuł:
Plexiform fibrohistiocytic tumor: a clinicopathological and immunohistochemical study of 39 tumors, with evidence for a CSF1-producing "null cell" population.
Autorzy:
Thangaiah JJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 59005, USA.
Dashti NK; Department of Pathology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
Agaimy A; Institute of Pathology, University Hospital Erlangen, Erlangen, Germany.
Fritchie K; Department of Pathology, Cleveland Clinic Foundation, Cleveland, OH, USA.
Folpe AL; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 59005, USA. .
Pokaż więcej
Źródło:
Virchows Archiv : an international journal of pathology [Virchows Arch] 2022 Nov; Vol. 481 (5), pp. 739-750. Date of Electronic Publication: 2022 Sep 07.
Typ publikacji:
Journal Article
MeSH Terms:
Biomarkers, Tumor*
Skin Neoplasms*/pathology
Adult ; Female ; Humans ; Male ; Young Adult ; Immunohistochemistry ; Ki-67 Antigen ; Neoplasm Recurrence, Local ; Child, Preschool ; Child ; Adolescent ; Middle Aged
Czasopismo naukowe
Tytuł:
Advances in the DNA Nanotechnology for the Cancer Biomarkers Analysis: Attributes and Applications.
Autorzy:
Xia LY; Biliary Surgical Department of West China Hospital, Sichuan University, Chengdu, Sichuan 610064, PR China; Analytical & Testing Center, Sichuan University, Chengdu, Sichuan 610064, PR China.
Tang YN; Analytical & Testing Center, Sichuan University, Chengdu, Sichuan 610064, PR China.
Zhang J; Biliary Surgical Department of West China Hospital, Sichuan University, Chengdu, Sichuan 610064, PR China.
Dong TY; College of Chemistry, Sichuan University Chengdu, Sichuan 610064, PR China.
Zhou RX; Biliary Surgical Department of West China Hospital, Sichuan University, Chengdu, Sichuan 610064, PR China. Electronic address: .
Pokaż więcej
Źródło:
Seminars in cancer biology [Semin Cancer Biol] 2022 Nov; Vol. 86 (Pt 2), pp. 1105-1119. Date of Electronic Publication: 2022 Jan 01.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomarkers, Tumor*/analysis
Neoplasms*/diagnosis
Neoplasms*/genetics
Neoplasms*/metabolism
Humans ; Nanotechnology/methods ; DNA ; Enzyme-Linked Immunosorbent Assay/methods ; Biomarkers
Czasopismo naukowe
Tytuł:
TIMP3::ALK fusions characterize a distinctive myxoid fibroblastic tumor of the vocal cords: a report of 7 cases.
Autorzy:
Klubíčková N; Department of Pathology, Charles University, Faculty of Medicine in Pilsen, Alej Svobody 80, 323 00, Pilsen, Czech Republic. .; Bioptical Laboratory, Ltd., Pilsen, Czech Republic. .
Michal M; Department of Pathology, Charles University, Faculty of Medicine in Pilsen, Alej Svobody 80, 323 00, Pilsen, Czech Republic.; Bioptical Laboratory, Ltd., Pilsen, Czech Republic.
Agaimy A; Institute of Pathology, Friedrich-Alexander University Erlangen-Nürnberg, University Hospital Erlangen (UKER), Erlangen, Germany.
Zidar N; Institute of Pathology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Pavlovský M; Department of Pathology, Regional Hospital Most, Most, Czech Republic.
Yorita K; Department of Diagnostic Pathology, Japanese Red Cross Kochi Hospital, Kochi, Japan.
Grossmann P; Bioptical Laboratory, Ltd., Pilsen, Czech Republic.
Hájková V; Bioptical Laboratory, Ltd., Pilsen, Czech Republic.
Ptáková N; Bioptical Laboratory, Ltd., Pilsen, Czech Republic.
Šteiner P; Bioptical Laboratory, Ltd., Pilsen, Czech Republic.
Michal M; Department of Pathology, Charles University, Faculty of Medicine in Pilsen, Alej Svobody 80, 323 00, Pilsen, Czech Republic.; Bioptical Laboratory, Ltd., Pilsen, Czech Republic.
Pokaż więcej
Źródło:
Virchows Archiv : an international journal of pathology [Virchows Arch] 2022 Nov; Vol. 481 (5), pp. 721-729. Date of Electronic Publication: 2022 Aug 04.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Vocal Cords*
Biomarkers, Tumor*/genetics
Female ; Humans ; Male ; Middle Aged ; Immunohistochemistry ; Gene Fusion ; Proteoglycans/genetics ; Receptor Protein-Tyrosine Kinases/genetics ; Tissue Inhibitor of Metalloproteinase-3/genetics
Czasopismo naukowe
Tytuł:
Advances in sex disparities for cancer immunotherapy: unveiling the dilemma of Yin and Yang.
Autorzy:
Ma J; Department of Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology, Tianjin, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, 300060, China.
Yao Y; Department of Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology, Tianjin, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, 300060, China.
Tian Y; Department of Senior Ward, National Clinical Research Center for Cancer, Key Laboratory of Molecular Cancer Epidemiology of Tianjin, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
Chen K; Department of Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology, Tianjin, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, 300060, China.
Liu B; Department of Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology, Tianjin, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, 300060, China. .
Pokaż więcej
Źródło:
Biology of sex differences [Biol Sex Differ] 2022 Oct 22; Vol. 13 (1), pp. 58. Date of Electronic Publication: 2022 Oct 22.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomarkers, Tumor*
Neoplasms*/therapy
Female ; Humans ; Male ; Immunotherapy ; Immunity
Czasopismo naukowe
Tytuł:
Autoantibody against Tumor-Associated Antigens as Diagnostic Biomarkers in Hispanic Patients with Hepatocellular Carcinoma.
Autorzy:
Ma Y; Department of Biological Sciences & NIH-Sponsored Border Biomedical Research Center, The University of Texas at El Paso, El Paso, TX 79968, USA.
Qiu C; Department of Biological Sciences & NIH-Sponsored Border Biomedical Research Center, The University of Texas at El Paso, El Paso, TX 79968, USA.
Wang B; Department of Leukemia, The University of Texas at MD Anderson Cancer Center, Houston, TX 77030, USA.
Zhang X; Department of Biological Sciences & NIH-Sponsored Border Biomedical Research Center, The University of Texas at El Paso, El Paso, TX 79968, USA.
Wang X; Department of Biological Sciences & NIH-Sponsored Border Biomedical Research Center, The University of Texas at El Paso, El Paso, TX 79968, USA.
Aguilera RJ; Department of Biological Sciences & NIH-Sponsored Border Biomedical Research Center, The University of Texas at El Paso, El Paso, TX 79968, USA.
Zhang JY; Department of Biological Sciences & NIH-Sponsored Border Biomedical Research Center, The University of Texas at El Paso, El Paso, TX 79968, USA.
Pokaż więcej
Źródło:
Cells [Cells] 2022 Oct 14; Vol. 11 (20). Date of Electronic Publication: 2022 Oct 14.
Typ publikacji:
Journal Article
MeSH Terms:
Antigens, Neoplasm*/immunology
Autoantibodies*/blood
Biomarkers, Tumor*/immunology
Carcinoma, Hepatocellular*/blood
Carcinoma, Hepatocellular*/diagnosis
Liver Neoplasms*/blood supply
Liver Neoplasms*/diagnosis
Antibodies, Neoplasm*/blood
Humans ; Endoplasmic Reticulum Chaperone BiP/immunology ; Hispanic or Latino ; Proteome
Czasopismo naukowe
Tytuł:
The importance of ancestry to understanding tumor mutation burden in cancer.
Autorzy:
Snyder A; Generate Biomedicines, Boston, MA, USA. Electronic address: .
McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Genome Evolution Research Group, University College London Cancer Institute, London, UK.
Pokaż więcej
Źródło:
Cancer cell [Cancer Cell] 2022 Oct 10; Vol. 40 (10), pp. 1076-1078. Date of Electronic Publication: 2022 Sep 29.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Comment
MeSH Terms:
Biomarkers, Tumor*/genetics
Neoplasms*/genetics
Neoplasms*/pathology
Neoplasms*/therapy
Asians ; Humans ; Immunotherapy ; Mutation ; Tumor Burden
Czasopismo naukowe
Tytuł:
Characteristics of abnormal subjects in screening of tumor markers among middle-aged and elderly people in Weihai area.
Autorzy:
Gao HG; 970 Hospital of the People's Liberation Army, Weihai, Shandong, China. .
Bi KX
Liang XL
Tang XD
Du LL
Wang CB
Pokaż więcej
Źródło:
European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] 2022 Oct; Vol. 26 (19), pp. 7084-7090.
Typ publikacji:
Journal Article
MeSH Terms:
Biomarkers, Tumor*
Lung Neoplasms*/diagnosis
Middle Aged ; Humans ; Aged ; Carcinoembryonic Antigen ; Early Detection of Cancer ; China
Czasopismo naukowe
Tytuł:
Effect of exercise on tumor markers - Is exercise anti-tumorigenic in humans?: A scoping review of preliminary clinical investigations.
Autorzy:
Kang DW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA.
Barnes O; Green Templeton College, University of Oxford, Oxford, USA.
Vander Heiden MG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Koch Institute for Integrative Cancer Research and the Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
Dieli-Conwright CM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA. Electronic address: ChristinaM_.
Pokaż więcej
Źródło:
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2022 Oct; Vol. 178, pp. 103779. Date of Electronic Publication: 2022 Aug 05.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Biomarkers, Tumor*
Breast Neoplasms*/diagnosis
Breast Neoplasms*/therapy
Carcinoembryonic Antigen ; Carcinogenesis ; Humans ; Ki-67 Antigen ; Male ; Prostate-Specific Antigen
Czasopismo naukowe
Tytuł:
Comprehensive analysis of tumor mutation burden and immune microenvironment in prostate cancer.
Autorzy:
Liao J; Medical Laboratory Science, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400042, China.
Ye Y; Clinical Laboratory, Chongqing Nanchuan Maternity and Child Healthcare Hospital, Chongqing, 408400, China.
Xu X; Clinical Laboratory, The People's Hospital of Nanchuan, Chongqing, No.16, Nandajie Road, Nanchuan District, Chongqing, 408400, China. .
Pokaż więcej
Źródło:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2022 Oct; Vol. 24 (10), pp. 1986-1997. Date of Electronic Publication: 2022 Jun 23.
Typ publikacji:
Journal Article
MeSH Terms:
Biomarkers, Tumor*
Prostatic Neoplasms*
Humans ; Immunotherapy ; Male ; Mutation ; Prognosis ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Prognostic value of TIGIT in East Asian patients with solid cancers: A systematic review, meta-analysis and pancancer analysis.
Autorzy:
Li S; School of Pharmacy, Peking University Health Science Centre, Beijing, China.
Li L; School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Pan T; School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Li X; Center of Disease Prevention Treatment, The Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing, China.
Tong Y; Institute of Medical Information, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China.
Jin Y; Department of Medical Oncology, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2022 Sep 21; Vol. 13, pp. 977016. Date of Electronic Publication: 2022 Sep 21 (Print Publication: 2022).
Typ publikacji:
Meta-Analysis; Systematic Review
MeSH Terms:
Biomarkers, Tumor*/genetics
Biomarkers, Tumor*/metabolism
Neoplasms*/genetics
Neoplasms*/immunology
Neoplasms*/metabolism
Receptors, Immunologic*/genetics
Receptors, Immunologic*/metabolism
CD8-Positive T-Lymphocytes ; Carcinogenesis ; Humans ; Microsatellite Instability ; Prognosis ; Receptors, Chemokine ; Tumor Microenvironment/genetics
Raport

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz